Recent federal developments may soon require cosmetic companies to adopt stringent precautions to ensure that talc-containing ...
Therapeutics announced that the U.S. FDA has granted Fast Track designation for rezpegaldesleukin for the treatment of adult and ...
Colorado's cannabis testing loopholes have led to consumers being deceived about the safety of the products they buy, with ...
This article is authored by Ranjit Barshikar, CEO, QbD International, CGMP Consulting, United Nations Adviser.
Exo-Top was established under the jurisdiction of the State of Nevada. Basing Exo-Top in the U.S. offers key advantages, including proximity to strategic partners, access to a robust biopharma ...
Such growth makes China an increasingly important player in the global biopharmaceutical industry, offering potential market ...
Genentech Inc. won regulatory approval Tuesday to market an eye implant that can be refilled every six months with an already ...
On January 7, 2025, the US Food and Drug Administration (FDA) issued two parallel guidance documents for the Section 503A and Section 503B bulk ...
The fallout from the F.D.A.’s rejection of MDMA-assisted treatment for PTSD worries researchers and experts who fear other ...
The proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.
7d
Zacks.com on MSNBiogen Stock Down on Regulatory Update in the EU for Alzheimer's DrugBiogen BIIB and Japan-based partner, Eisai, announced an update regarding the regulatory review of an application seeking the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results